A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06055075 · COMPLETED
Trial details
- NCT number
- NCT06055075
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-12
- Primary completion
- 2025-07-08
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.